ICU kidney dialysis: which dose of blood thinner works best?
NCT ID NCT07469072
First seen Mar 15, 2026 · Last updated May 14, 2026 · Updated 7 times
Summary
This study compares two starting doses (20 mg/h vs 50 mg/h) of the blood thinner nafamostat in ICU patients receiving continuous kidney dialysis. The goal is to see which dose keeps the dialysis filter working longer without causing dangerous bleeding. About 92 adults with normal clotting will be randomly assigned to one of the two doses.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CONTINUOUS RENAL REPLACEMENT THERAPY (CRRT) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Department of Critical Care Medicine of Zhujiang Hospital,Southern Medical University
RECRUITINGGuangzhou, Guangdong, 510282, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.